Insulin administration is recommended for patients with glycated hemoglobin levels >9% and those whose diabetes cannot be controlled using oral glycemic therapy (Marín-Peñalver et al., 2016) (Thrasher, 2017). The gene discussed is INS; the disease is diabetes mellitus.